Buyside firms are accelerating order and execution-management system upgrades, though adoption cycles are polarized, with ...

Impax US Sustainable Economy Fund is a systematic strategy investing in US large cap companies we believe are positioned to ...

DXC Technology (NYSE: DXC), a leading enterprise technology and innovation partner, today announced the appointment of ...

Technology has entered the daily lives of the 50-plus demographic, making life easier and offering older adults more control ...

Kaynes Technology tumbled 27% in 3 days after a domestic institution flagged inconsistencies in FY2025 disclosures, sparking ...

Endava research shows 92% of leaders feel prepared for agentic AI, but only 36% have funded strategies to implement the ...

Intel rallied strongly in September as the company announced a partnership with Nvidia on integrating Intel’s x86 central ...

Yardeni Research is no longer "overweight" on the "Magnificent 7", ending a 15-year bullish stance on U.S. tech stocks on worries over elevated concentration and opportunities in the broader market.

Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are ...

While $11 billion is a lot of money to spend, IBM is betting that acquiring Confluent and its popular data streaming platform ...

Tech giants have agreed to blur online images of pornography and violence just weeks after Australia’s world-first ban on ...

Yardeni Research downgrades Magnificent 7 after 15 years, urging investors to shift toward the broader S&P 500 amid rising ...